ZBIO

23.8504.75%
HL

Haley Laken

Chief Scientific Officer

Dr. Haley Laken, Ph.D., is Chief Scientific Officer of Zenas BioPharma, Inc. & Zenas BioPharma Limited from April 2025. Dr. Laken served as Senior Vice President of Program and Portfolio Strategy at Jounce Therapeutics, Inc. since 2021 to August 1, 2022 and served as its Chief Development Officer from August 1, 2022 until 2023. Dr. Laken served as Chief Operating Officer at Tabby Therapeutics. She joined Jounce in March 2018 and has experience in biotech and pharmaceutical large molecule drug development strategy and execution, culminating as Chief Development Officer and a member of the executive team. Dr. Laken is Director at InCephalo Therapeutics. Prior to joining Jounce, Dr. Laken established the immunotherapy pipeline at TESARO. She was also instrumental in the development of the program leadership and management function during a period of rapid growth and transition to a commercial stage company. Dr. Laken has held positions of increasing strategic drug development leadership at Rhythm Pharmaceuticals, Pfizer and Wyeth. Dr. Laken received her Ph.D. in human genetics and molecular biology from Johns Hopkins University and a B.A. in biology from DePauw University.

Positions